Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: Are We Doing Enough?
Our findings indicate that, although testing frequency for liver health in patients with type 2 diabetes is gradually increasing, substantial gaps in clinical practice persist.
Authors
- Paul Y. Kwo (ORCID: https://orcid.org/0000-0002-8234-4485)
- Gavin Hui (ORCID: https://orcid.org/0000-0002-4818-4254)
- Sun H. Kim (ORCID: https://orcid.org/0000-0003-0895-7491)
- Marcie Levine
- C. William Pike (ORCID: https://orcid.org/0000-0002-2166-1559)
- Michael L. Jackson (ORCID: https://orcid.org/0000-0002-2340-0256)
Institutions
- Palo Alto University (US)
- Stanford Medicine (US)
- New York Chiropractic College (US)
- Stanford University (US)
Publication Details
- Journal
- Diabetes Spectrum
- Published
- 2025-09-23
- DOI
- https://doi.org/10.2337/ds25-0028
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00